In addition, both S100A9 and IL-18 were shown to drive accumulation and activation of myeloid-derived suppressor cells (MDSCs) that promote immune suppression and tolerance, contributing to the biological phenotype of clonal evolution and ineffective hematopoiesis in MDS [24,27,28]. The gene discussed is S100A9; the disease is myelodysplastic syndrome.